Transcript on Earning call held on 12.08.2026 is attached.

Date: August 17, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Plot No. C/1, G Block, Mumbai – 400 001 Bandra Kurla Complex, Bandra (East), Mumbai – 400 051 Scrip Code: 544733 Trading Symbol: GSPCROP Dear Sir/Madam, Sub: Transcript of the Post Results Conference Call on Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, transcript of the post Results Conference Call on Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026, held on August 12, 2026, is available on the Company’s website at: https://cdn.prod.website- files.com/64a41d7fe20bb4386d083958/6a82e41a070a695279ea52eb_Earnings%20Call%20Transcri pt%20-%2012.8.26.pdf You are requested to take the same on your record. Thanking you. Yours faithfully, For GSP Crop Science Limited Kamleshbhai D Patel Company Secretary & Compliance Officer M. No. FCS 8018 Encl: As above “GSP Crop Science Limited Q1 FY27 Earnings Conference Call” August 12, 2026 E&OE: This transcript is edited for factual errors. In case of discrepancy, the audio recording uploaded on the stock exchange will prevail. MANAGEMENT: MR. BHAVESH SHAH – CHAIRMAN AND MANAGING DIRECTOR – GSP CROP SCIENCE LIMITED MR. SHAIL SHAH – EXECUTIVE DIRECTOR - STRATEGY & CORPORATE AFFAIRS – GSP CROP SCIENCE LIMITED Page 1 of 14 GSP Crop Science Limited August 12, 2026 Moderator: Ladies and gentlemen, good day and welcome to the GSP Crop Science Limited's Q1 FY27 Earnings Conference Call. As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during this conference call, please signal an operator by pressing star, then zero on your touchtone phone. Please note that this conference is being recorded. This conference call may contain forward- looking statements about the company which are based on the beliefs, opinions, and expectations of the company as on the date of this call. These statements do not guarantee the future performance of the company and may involve risks and uncertainties that are difficult to predict. I now hand the conference over to Mr. Bhavesh Shah, Managing Director from GSP Crop Science Limited. Thank you, and over to you, sir. Bhavesh Shah: Yes. Good morning, everyone, and thank you for joining us today on our Q1 FY27 earning call. I am Bhavesh Shah, MD and Chairman of the company. With me Shail Shah, Executive Director, and also Adfactors PR our IR agency. I hope all of you have had the opportunity to review our financial results for the first quarter ‘27. Overall, the financial performance in Q1 FY27 was stable, especially considering the volatile operations environments. We are a research-driven agrochemical company specializing in the development and manufacturing of insecticides, herbicides, and fungicides, also plant PGR in India. With over more than 40 years’ experience in the agrochemical industries, GSP is built on a strong foundation of diversified product portfolio of technical and formulations, established customer relationship and growing presence across domestic and international market. As a core of our business in our manufacturing capability, we operate multiple manufacturing facilities across India producing both technical and formulations. Technical form the active ingredient used in crop protection products, while formulations are the finished products that ultimately reach farmers. At GSP, we are not a single format agrochemical company, rather an integrated one. Some companies in India are only making formulations and some only manufacturing technical. We are doing both technical and manufacturing. We operate across three diversified channels: a domestic B2B, domestic B2C, and also export. Now, we have more than 6000 distributors in India. Our comprehensive portfolio for the domestic market includes more than 200 product formulations, also more than 70 technicals. Page 2 of 14 GSP Crop Science Limited August 12, 2026 Strong innovation pipeline, us we have more than 100 patent already granted product, and also, we have applied more than 100 applications under process. Our export portfolio also we have almost 175 plus formulations and 60 plus technical product giving the capability to address diverse crop protections needs across market. Also, we have invested in backward integrations to manufacturing of technical to lower our dependency on import. Allow me to throw some light on patent and product strategy. Many large global players have patented products of technical. As those patent approach expiry, we position ourselves to be among the first movers in India to launch the new molecule in domestically. A multilayered effort involving field trials, safety testing, R&D and other regulatory clearance for Indian market. This result, we are the first-generation product, as a first-generation product we are the first mover in India to launch introduce the products. And that gives us as a first mover advantage. In our portfolio we also create proprietary independently patented combination product also that address broader spectrum of pest or crop issue. Our life cycle of a molecule this allows us to monetize it twice. First, as a sustainable and standalone product, which naturally commodities as a more players enters and second, as a product gets resistance, so we are getting we are introducing a proprietary combinations which is a sustainable, and also, price power also margin, and also, we are getting molecule as once got generic of old product, we introduce a patented product. And with this combination patent product -- patented product, GSP also getting a good margin. And also, farmers are getting a very good product for longer product control and also, they are getting reasonable price so they can get more yield by using this new patented product. In our history also few years, we have launched many products, patented product, and with excellent control with longer residual control. And with that, we are very strong in many crops like paddy, sugarcane, vegetables, pulses, cotton and also in future also we are planning to launch many patented product because we have more than 200 product in our portfolio patented product. So, it will continue and in future also and for that farmer will get good product and even our margin will continue as a sustainable margin and will get and also our growth will be very good. So, for financial, so I am handover to Shail Shah, Executive Director. Shail Shah: Yes. Thank you, Bhavesh sir. Good morning, everyone. I will now take you through the financial performance of the company for the quarter one of FY27. During the quarter, the company has reported a revenue of INR386 crores as compared to INR377 crores in the last quarter of the -- quarter one of the last financial years. Revenue remained broadly stable during the quarter with strong momentum in the domestic business. However, it was partly offset by temporary raw material constraints in the international business. Within our domestic business if you have to see as Bhavesh sir just mentioned, our focus on the patented portfolio, we are seeing good growth in the volumes of the products that we have Page 3 of 14 GSP Crop Science Limited August 12, 2026 recently launched like PCT 410 and the products like Fighter who are gaining good scales and good volumes. We have seen good growth in these products in the quarter one. Along with this, we have also seen a good growth and momentum from our B2B customers who have been co-marketing these patented products with us. So, as a strategy when we are launching these products, these combinations in our B2C business, we also offer these products to our co- marketers in our B2B business t [Showing first 8,000 characters — download PDF for full document]